表觀遺傳學全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計表觀遺傳學市場將從 2025 年的 288 億美元成長到 2034 年的 1,562.6 億美元，2026 年至 2034 年的複合年成長率為 20.67%。

全球表觀遺傳學市場正經歷快速成長，這主要得益於對基因表現和疾病機制研究的不斷深入。表觀遺傳學研究的是環境因素和化學修飾如何在不改變DNA序列的情況下影響基因活性。隨著人們對個人化醫療的日益關注以及分子生物學技術的進步，表觀遺傳學在疾病診斷、藥物研發和治療方法開發等領域的應用正顯著擴展，遍及整個醫療保健行業。

多種因素正在推動表觀遺傳學市場的擴張。癌症、心血管疾病和神經系統疾病等慢性病的日益普遍，增加了對先進診斷工具和標靶治療的需求。此外，基因組技術的不斷進步，包括定序和生物資訊學，使研究人員能夠更有效地研究表觀遺傳修飾。政府資助以及研究機構與生物技術公司之間合作的加強也促進了市場成長。

隨著對基因表現調控的科學認知不斷加深，表觀遺傳學市場預計將穩定成長。表觀遺傳療法和精準醫療方法的發展有望革新複雜疾病的治療策略。此外，生物技術研發投入的增加以及表觀遺傳生物標記臨床應用的不斷拓展，預計將為市場帶來創新和長期成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球表觀遺傳學市場：依產品分類

• 市場分析、洞察與預測
• 酵素
• 設備和耗材
• 成套工具
• 試劑

第5章：全球表觀遺傳學市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 非腫瘤區域

第6章 全球表觀遺傳學市場：依技術分類

• 市場分析、洞察與預測
• DNA甲基化
• 組蛋白甲基化
• 組蛋白乙醯化
• 大型非編碼RNA
• 微型RNA修飾
• 染色質結構

第7章 全球表觀遺傳學市場：依最終使用者分類

• 市場分析、洞察與預測
• 學術研究機構
• 製藥公司和生技公司
• 受託研究機構（CRO）

第8章 全球表觀遺傳學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • F. Hoffmann La Roche Ltd
  • Novartis AG
  • Merck KGaA
  • Illumina Inc
  • Qiagen NV
  • Pacific Biosciences Of California Inc
  • Bio Techne Corporation
  • Promega Corporation
  • Zymo Research Corporation
  • New England Biolabs Inc
  • Abcam Plc
  • Active Motif Inc
  • Diagenode SA
  • GeneTex Inc

The Epigenetics Market size is expected to reach USD 156.26 Billion in 2034 from USD 28.80 Billion (2025) growing at a CAGR of 20.67% during 2026-2034.

The global epigenetics market has witnessed rapid growth due to increasing research activities focused on understanding gene expression and disease mechanisms. Epigenetics studies how environmental factors and chemical modifications influence gene activity without altering the DNA sequence. Growing interest in personalized medicine and advancements in molecular biology technologies have significantly expanded the applications of epigenetics in disease diagnosis, drug discovery, and therapeutic development across the healthcare sector.

Several factors are driving the expansion of the epigenetics market. Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has increased demand for advanced diagnostic tools and targeted treatments. Additionally, continuous advancements in genomic technologies, including sequencing and bioinformatics, are enabling researchers to study epigenetic modifications more effectively. Government funding and increasing collaboration between research institutions and biotechnology companies are also supporting market growth.

In the future, the epigenetics market is expected to grow steadily as scientific understanding of gene regulation continues to improve. The development of epigenetic therapies and precision medicine approaches may transform treatment strategies for complex diseases. Furthermore, increasing investments in biotechnology research and expanding clinical applications of epigenetic biomarkers are likely to create significant opportunities for innovation and long-term growth in this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Enzymes
• Instruments and Consumables
• Kits
• Reagents

By Application

• Oncology
• Non-Oncology

By Technology

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large non-coding RNA
• MicroRNA Modification
• Chromatin Structures

By End User

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Novartis AG, Merck KGaA, Illumina Inc, Qiagen NV, Pacific Biosciences of California Inc, Bio Techne Corporation, Promega Corporation, Zymo Research Corporation, New England Biolabs Inc, Abcam plc, Active Motif Inc, Diagenode SA, GeneTex Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EPIGENETICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EPIGENETICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EPIGENETICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. DNA Methylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Histone Methylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Histone Acetylation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Large non-coding RNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. MicroRNA Modification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Chromatin Structures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EPIGENETICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical Companies and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EPIGENETICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EPIGENETICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 F. Hoffmann La Roche Ltd
  • 10.2.3 Novartis AG
  • 10.2.4 Merck KGaA
  • 10.2.5 Illumina Inc
  • 10.2.6 Qiagen N.V
  • 10.2.7 Pacific Biosciences Of California Inc
  • 10.2.8 Bio Techne Corporation
  • 10.2.9 Promega Corporation
  • 10.2.10 Zymo Research Corporation
  • 10.2.11 New England Biolabs Inc
  • 10.2.12 Abcam Plc
  • 10.2.13 Active Motif Inc
  • 10.2.14 Diagenode S.A
  • 10.2.15 GeneTex Inc